Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis
By NEVAGiles23
A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients. "Autologous Stromal Vascular Fraction Therapy for Rheumatoid Arthritis: Rationale and Clinical Safety," which appears in the January publication of the International Archives of Medicine, followed 13 rheumatoid arthritis patients who were treated with their own fat-derived stem cells.
Dallas, TX (PRWEB) February 21, 2012
A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients. "Autologous Stromal Vascular Fraction Therapy for Rheumatoid Arthritis: Rationale and Clinical Safety," which appears in the January publication of the International Archives of Medicine, followed 13 rheumatoid arthritis patients who were treated with their own fat-derived stem cells.
Treating arthritis with fat-derived stem cells has become commonplace in veterinary medicine over the past five years with over 7,000 horses and dogs treated by publication contributor Vet-Stem, a San Diego-based company. The objective of the joint Panamanian-US study was to determine feasibility of translating Vet-Stem's successful animal results into human patients.
Observing no treatment associated adverse reactions after one year, the team concluded that its protocol should be studied further to determine efficacy in the treatment of rheumatoid arthritis. Their publication details the rationale for the use of fat derived stem cells in treatment of autoimmune conditions and is freely available at: http://www.intarchmed.com/content/pdf/1755-7682-5-5.pdf
“Key to advancement of any medical protocol is transparent disclosure of rationale, treatment procedures and outcomes to the research community in a peer-reviewed and IRB-compliant manner,” said Dr. Jorge Paz Rodriguez, Medical Director of the Stem Cell Institute and research team leader. “While we have previously published case studies on the use of fat stem cells in multiple sclerosis patients, and one rheumatoid arthritis patient, this is the first time that comprehensive follow-up has been completed for a larger cohort of patients,” he added.
An important distinction that separates this particular approach from those which are being explored by several international investigators is that the fat stem cells were not grown in a laboratory, affording a substantially higher level of safety and protocol practicality.
“This work signifies Panama's emergence into the burgeoning field of translational medicine,” commented Dr. Ruben Berrocal Timmons, the Panamanian Secretary of Science and publication co-author. “We are proud to have attracted and collaborated with internationally-renowned stem cell clinical researchers such as Dr. Michael Murphy and Dr. Keith March from the Indiana University School of Medicine Center for Vascular Biology and Medicine, Dr. Boris Minev from the University of California, San Diego Moores Cancer Center, Dr. Chien Shing Chen from Loma Linda University Behavioral Medicine Center and Dr. Bob Harman from Vet-Stem. By leveraging their vast, collective clinical experience with Panamanian scientific infrastructure and know-how, we are striving to develop effective, internationally recognized stem cell procedures that will be accepted the world over.”
The treatment procedure involves a mini-liposuction, collection of the fat's cellular component, processing to obtain a population of cells that includes stem cells, freezing the cells in preparation for quality control, and subsequent re-administration of the cells into patients.
The Panamanian-US group has previously shown that there is a specific type of T cell, called the T regulatory cell, associated with fat stem cells, which is capable of suppressing pathological immunity. Their current theory, which is described in detail in the publication: http://www.ncbi.nlm.nih.gov/pubmed/20537320, is that the T regulatory component of the fat is capable of slowing down or suppressing the “autoimmune” reaction, while the stem cell component causes formation of new tissue to replace the damaged joints.
About the Stem Cell Institute
Founded in 2006 on the principles of providing unbiased, scientifically-sound treatment options, the Stem Cell Institute has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, the institute’s doctors treat carefully selected patients with spinal cord injury, osteoarthritis, heart disease, multiple sclerosis, rheumatoid arthritis and other autoimmune diseases. Doctors at The Stem Cell Institute have treated over 1000 patients to-date.
For more information on stem cell therapy:
Stem Cell Institute Web Site: http://www.cellmedicine.com
Facebook: http://www.facebook.com/stemcellinstitute
Blogger: http://www.adult-stem-cell-therapy.blogspot.com
Stem Cell Institute
Via Israel & Calle 66
Pacifica Plaza Office #2A
San Francisco, Panama
Republic of Panama
Phone: +1 800 980-STEM (7836) (USA Toll-free) +1 954 636-3390 (from outside USA)
Fax: +1 866 775-3951 (USA Toll-free) +1 775 887-1194 (from outside USA)
###
Jay Lenner
jdlenner@cellmedicine.com
1-800-980-7836
Email Information
Read more from the original source:
Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis
- Hemostemix steps into the new year with capital and its critical clinical study data in hand - InvestorIntel - January 9th, 2021
- Glioblastoma Tumors Triggered by the Healing Process of Brain Injury - Science Times - January 9th, 2021
- Stem Cell Assay Market Competitive Landscape Analysis with Forecast by 2025 - SoccerNurds - January 9th, 2021
- COVID-19 : Coronavirus I The hopeful treatment against COVID-19 with stem cells from the umbilical cord - Explica - January 9th, 2021
- January 2021: 2020 Papers of the Year - Environmental Factor Newsletter - January 5th, 2021
- Global Cell Therapy Market Report 2020: Market to Recover in 2023 - PRNewswire - January 3rd, 2021
- Regenerative Medicine: Market Trends and Legal Developments on the Horizon for 2021 - MedTech Intelligence - December 13th, 2020
- Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo - Science Advances - December 6th, 2020
- New Drug Could Improve Effectiveness of Stem Cell Therapy - Pain News Network - December 1st, 2020
- Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 - Times of San Diego - November 28th, 2020
- Scientists Reveal a New Drug That Directs Stem Cells To Desired Sites - Science Times - November 26th, 2020
- Global Stem Cells Market is estimated to account for US$ 18289.9 Mn by end of 2027, Says Coherent Market Insights (CMI) - Business Wire - November 23rd, 2020
- How regenerative medicine could be used to contain COVID-19, others - Guardian - November 21st, 2020
- The Spinal Cord Trauma Treatment Market To Walk The Path Of Double Digit CAGR Of 3.7% - KYT24 - November 18th, 2020
- The Spinal Cord Trauma Treatment Market To Witness A Substantial Demand Amidst Covid-19, To Reach US$ 3000 Mn - The Think Curiouser - November 10th, 2020
- The story of mRNA: From a loose idea to a tool that may help curb Covid - STAT - November 10th, 2020
- Worldwide Regenerative Medicine Industry to 2025 - Featuring Allergan, Amgen and Baxter International Among Others - PRNewswire - November 10th, 2020
- Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview -... - November 8th, 2020
- Regenerative Medicine Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025 - Eurowire - November 5th, 2020
- Deep conservation of the enhancer regulatory code in animals - Science Magazine - November 5th, 2020
- Global Regenerative Medicine Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com -... - November 5th, 2020
- California Prop. 14: What to know about the stem cell measure - Los Angeles Times - November 3rd, 2020
- How pain changes your brain - News - The University of Sydney - November 3rd, 2020
- The Neuroprosthetics market to stand in a good stead from 2015 to 2021 - KYT24 - November 3rd, 2020
- Neuroprosthetics Market: Increasing Prevalence of Diabetes in Neuroprosthetics investigated in the latest research - WhaTech - November 3rd, 2020
- Philadelphia Based Company Wants to Bring Back the Dead With Stem Cells - Gilmore Health News - November 1st, 2020
- Outlook on the Regenerative Medicine Global Market to 2025 - Impact of COVID-19 on the Market - GlobeNewswire - October 30th, 2020
- Rising Adoption of Cell Therapy Processing Market by 2020-2027 with Major Giants: BioTime, Inc., Regeneus Ltd., Targazyme, Inc., Bone Therapeutics,... - October 30th, 2020
- QurAlis Announces Appointment of New Chief Medical Officer and Formation of Clinical Advisory Board - BioSpace - October 30th, 2020
- Tag: Animal Stem Cell Therapy Market - TMR Research Blog - October 29th, 2020
- The Neuroprosthetics market to grow in the wake of incorporation of the latest technology - PRnews Leader - October 29th, 2020
- Stem cell treatment after spinal cord injury: The next ... - October 27th, 2020
- What We Know So Far about How COVID Affects the Nervous System - Scientific American - October 23rd, 2020
- Stem Cell Assay Market expected to Witness a Sustainable Growth over 2025 - TechnoWeekly - October 23rd, 2020
- Stem Cell Therapies for Spinal Cord Injuries - October 17th, 2020
- Disruptive Technologies and Mature Regulatory Environment Vital for Cell Therapy Maturation - BioSpace - October 17th, 2020
- Should California invest $5.5 billion more into promising ... - October 17th, 2020
- What is human fetal tissue research and why is it done - Business Insider - Business Insider - October 17th, 2020
- Prop. 14: In the COVID age, can California still afford its stem cell research program? - CALmatters - October 16th, 2020
- Animal Stem Cell Therapy Market - Great Growth Opportunities for the Market in the Coming Year | TMR Research Study - BioSpace - October 6th, 2020
- UC Davis Engineers Lead $36M Effort to Improve Recovery From Spinal Cord Injuries - UC Davis - October 2nd, 2020
- What You Need to Know About Prop 14, The Stem Cell Research Bond (Transcript) - KQED - October 2nd, 2020
- SMART researchers receive Intra-CREATE grant for personalized medicine and cell therapy - MIT News - October 2nd, 2020
- The global market for Nerve Repair and Regeneration is projected to reach US$12.7 billion by 2025 - GlobeNewswire - September 29th, 2020
- MS treatment a step closer after drug shown to repair nerve coating - The Guardian - September 26th, 2020
- What treatments can prolong the life of someone with Alzheimer's? - Pledge Times - September 26th, 2020
- Species-specific pace of development is associated with differences in protein stability - Science Magazine - September 18th, 2020
- AgeX Therapeutics and Lineage Cell Therapeutics Announce Expansion of Agreement Related to ESI Clinical-grade Pluripotent Stem Cell Lines for... - September 9th, 2020
- Lineage Cell Therapeutics : AgeX Therapeutics and Lineage Cell Therapeutics Announce Expansion of Agreement Related to ESI Clinical-grade Pluripotent... - September 9th, 2020
- Global Cord Blood Banking Market 2020 with Analysis of 44 Industry Players - PRNewswire - September 3rd, 2020
- Royal Biologics Announces the Acquisition of FIBRINET - PRNewswire - September 1st, 2020
- BrainStorm to present data linking MR measures to functional improvement in progressive multiple sclerosis - DOTmed HealthCare Business News - August 26th, 2020
- AST-OPC1 Stem Cell Therapy Offers Hope for Spinal Cord Injury - August 25th, 2020
- Stem Cells for Spinal Disorders - A Nonsurgical, Minimally ... - August 25th, 2020
- Cell Transplantation for Spinal Cord Injury ... - August 25th, 2020
- Knowing the Global Cell Therapy Market; MRFR Reveals Insights for 2017 2023 - The Daily Chronicle - August 25th, 2020
- Liver Disease Stem Cell Therapy | NSI Stem Cell - August 24th, 2020
- Stem Cell Grafts Show Functionality in Spinal Cord Injuries - August 12th, 2020
- Repairing damage caused by spinal cord injury with stem cells - August 12th, 2020
- Implanted Neural Stem Cell Grafts Show Functionality in ... - August 12th, 2020
- New Study Presents Cell-based Therapy for MN Diseases or Spinal Cord Disorders - Mirage News - August 11th, 2020
- Re-Stem-Funded Study Targeting Mitochondrial Dysfunction in Aging and Age-Related Diseases Published in Science Advances Journal - Press Release -... - August 10th, 2020
- Could EPO be used to treat COVID-19? - Canadian Running Magazine - July 8th, 2020
- Revenue from the Sales of Neuroprosthetics Market to Increase Exponentially During 2015 2021 - 3rd Watch News - July 7th, 2020
- COVID-19 impact on Spinal Fusion Market Growth Analysis, Demand by Regions and Global Forecasts To 2025 | Charter, Worthington Industries, Cesca... - July 7th, 2020
- Lineage Cell Therapeutics Is A High-Risk But High-Reward Opportunity To Consider - Seeking Alpha - July 3rd, 2020
- Ionis, leading MS researcher throw antisense at a new type of brain cells - Endpoints News - July 3rd, 2020
- EPO doping drug appears to ease severe cases of COVID-19 - Innovation Origins - July 3rd, 2020
- Spinal Cord Trauma Treatment Market Size : Technological Advancement and Growth Analysis with Forecast to 2025 - 3rd Watch News - June 29th, 2020
- SFARI | SFARI workshop explores challenges and opportunities of gene therapies for autism spectrum disorder - SFARI News - June 25th, 2020
- Changing jobs: converting other cell types into neurons - HDBuzz - June 24th, 2020
- Stem Cell Assay Market In-Depth Analysis and Forecast 2017-2025 - Daily Veterans - June 24th, 2020
- Outlook on the Worldwide Regenerative Medicine Industry to 2024 - Rising Global Healthcare Expenditure Presents Opportunities - GlobeNewswire - June 23rd, 2020
- Personalized Cell Therapies Market Growth by 2025 Cytori Therapeutics, MolMed SpA - Cole of Duty - June 18th, 2020
- Stem Cells Without Ethical Implications Are Ready for the Spotlight - Press Release - Digital Journal - June 17th, 2020
- Augmenting Demand for Stem Cell Characterization and Analysis Tools to Bolster Global Market Revenue Growth During the Crisis Period of COVID 19 - 3rd... - June 16th, 2020
- Impact of Corona on Spinal Fusion Market Statistics, Investment Trends, Key Players and Forecast 2020-2026 | Cotton, Rayon, Blended - Cole of Duty - June 12th, 2020
- New Results From Landmark NURTURE Study Show That Pre-Symptomatic SMA Patients Treated With SPINRAZA (nusinersen) Continue to Demonstrate Sustained... - June 10th, 2020
- Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome - Science - June 10th, 2020
- Augmenting Demand for Stem Cell Characterization and Analysis Tools to Bolster Global Market Revenue Growth During the Crisis Period of COVID 19 - The... - June 10th, 2020
